Minimise Regulatory Risk in China with NSF’s Proven Compliance Framework
May 13, 2025
Avoid costly delays and compliance issues in China’s medical device market. NSF’s brochure outlines a proven framework for regulatory success.
Regulatory missteps in China can lead to costly delays, rejected applications, or even market withdrawal. NSF’s China Services Brochure presents a structured, risk-based approach to ensure your medical device meets NMPA standards—first time, every time.
Our compliance framework covers:
- Accurate classification and clinical pathway selection
- Gap analysis and documentation alignment with Chinese standards
- Proactive deficiency letter response strategies
- Post-market risk evaluation and AE reporting
- Renewal and change registration planning
Why it matters:
China’s regulatory environment is unique. NSF’s localised expertise and hands-on support help you avoid pitfalls and maintain uninterrupted market access.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Issues First-Ever MSC Certification for an Eel Fishery to Perupez S.A.C. and Sakana del Peru
June 19, 2026Third-party certification plays a key role in independently verifying the sustainability of seafood operations.
iNADO Partners with NSF to Support Members and Athletes
May 27, 2026iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation
May 20, 2026NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.